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Receptor-Mediated Oral Delivery of a Bioencapsulated Green Fluorescent Protein
Expressed in Transgenic Chloroplasts Into the Mouse Circulatory System
Abstract
Oral delivery of biopharmaceutical proteins expressed in plant cells should reduce their cost of
production, purification, processing, cold storage, transportation, and delivery. However, poor intestinal
absorption of intact proteins is a major challenge. To overcome this limitation, we investigate here the
concept of receptor-mediated oral delivery of chloroplast-expressed foreign proteins. Therefore, the
transmucosal carrier cholera toxin B-subunit and green fluorescent protein (CTB-GFP), separated by a
furin cleavage site, was expressed via the tobacco chloroplast genome. Polymerase chain reaction (PCR)
and Southern blot analyses confirmed site-specific transgene integration and homoplasmy. Immunoblot
analysis and ELISA confirmed expression of monomeric and pentameric forms of CTB-GFP, up to 21.3%
of total soluble proteins. An in vitro furin cleavage assay confirmed integrity of the engineered furin
cleavage site, and a GM1 binding assay confirmed the functionality of CTB-GFP pentamers. Following oral
administration of CTB-GFP expressing leaf material to mice, GFP was observed in the mice intestinal
mucosa, liver, and spleen in fluorescence and immunohistochemical studies, while CTB remained in the
intestinal cell. This report of receptor-mediated oral delivery of a foreign protein into the circulatory
system opens the door for low-cost production and delivery of human therapeutic proteins.
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Receptor-mediated oral delivery of a bioencapsulated green
fluorescent protein expressed in transgenic chloroplasts into
the mouse circulatory system
Arati Limaye1, Vijay Koya1, Mohtashem Samsam, and Henry Daniell2
Department of Molecular Biology and Microbiology, University of Central Florida, Biomolecular
Science, Orlando, Florida, USA

Abstract
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Oral delivery of biopharmaceutical proteins expressed in plant cells should reduce their cost of
production, purification, processing, cold storage, transportation, and delivery. However, poor
intestinal absorption of intact proteins is a major challenge. To overcome this limitation, we
investigate here the concept of receptor-mediated oral delivery of chloroplast-expressed foreign
proteins. Therefore, the transmucosal carrier cholera toxin B-subunit and green fluorescent protein
(CTB-GFP), separated by a furin cleavage site, was expressed via the tobacco chloroplast genome.
Polymerase chain reaction (PCR) and Southern blot analyses confirmed site-specific transgene
integration and homoplasmy. Immunoblot analysis and ELISA confirmed expression of
monomeric and pentameric forms of CTB-GFP, up to 21.3% of total soluble proteins. An in vitro
furin cleavage assay confirmed integrity of the engineered furin cleavage site, and a GM1 binding
assay confirmed the functionality of CTB-GFP pentamers. Following oral administration of CTBGFP expressing leaf material to mice, GFP was observed in the mice intestinal mucosa, liver, and
spleen in fluorescence and immunohistochemical studies, while CTB remained in the intestinal
cell. This report of receptor-mediated oral delivery of a foreign protein into the circulatory system
opens the door for low-cost production and delivery of human therapeutic proteins.
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One of the most challenging problems of human health management is the high cost of
prescription drugs in developed countries and their lack of availability in developing
countries. For example, interferon (IFN) alpha 2b is used for the treatment of viral diseases
such as hepatitis C, as well as for certain cancers. However, IFN treatment for four months
costs $26,000 in the United States, where more than forty-five million Americans do not
have health insurance (1). Several hundred million people in developing countries are
infected with hepatitis, but the daily income of one-third of the world population is less than
$2 per day (1). The high cost of prescription drugs is due to a number reasons, including
fermentation-based production (each fermenter costs several hundred million dollars to
build), expensive purification and in vitro processing methods (such as column
chromatography, disulfide bond formation) (2), the need for storage and transportation at
low temperature and delivery via sterile injections requiring the involvement of hospitals
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and highly qualified health professionals (1). Therefore, new approaches to minimize or
eliminate most of these expenses are urgently needed. Transgenic plants offer many
advantages, including the feasibility of the oral delivery of foreign proteins, low cost of
production, storage and transportation, heat stability and protection through
bioencapsulation, elimination of the need for expensive purification, in vitro processing, and
sterile injections (1–5). The generation of systemic and mucosal immunity (6) or induction
of oral tolerance (7), improved safety, and absence of human pathogens (3) are other
additional advantages (4, 5).
Chloroplast genetic engineering has recently become an attractive method for production of
recombinant proteins (8, 9) because of high concentration of transgene expression [up to
47% of the total soluble protein (10)] due to the presence of 10,000 copies of the transgene
per cell, which is uniquely advantageous for oral delivery of therapeutic proteins or vaccine
antigens. It is also an environmentally friendly approach due to effective gene containment
offered by maternal inheritance of chloroplast genomes in most crops (11, 12) or engineered
cytoplasmic male sterility (13). Multigene engineering in a single transformation event (10,
14, 15) should facilitate delivery of polyvalent vaccines or expression of therapeutic proteins
with multiple subunits.
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Despite these advantages, a major limitation remains in the efficient delivery of plantexpressed therapeutic proteins across the intestinal mucus membrane, primarily because of
poor permeability across the intestinal epithelial layer (16). Receptor-mediated oral delivery
across the intestine might serve as a possible way to deliver not only vaccines but also
biopharmaceutical proteins. Ganglioside M1 (GM1) receptors on the intestinal epithelial
cells have been utilized by various pathogens such as V. cholerae to facilitate entry of
cholera toxin, into the intestine.
Crystal structures (17–19) of bacterial toxins like cholera toxin, (CT), heat-labile enterotoxin
(LT), and shigella toxin show that they belong to AB5 subunit family. In CT, five identical
(11.6 kDa) peptides assemble into a highly stable pentameric ring called the B subunit (58
kDa). The nontoxic B subunit (CTB) exhibits specific and high-affinity binding to the
oligosaccharide domain of ganglioside GM1 (a lipid-based membrane receptor) and
functions to tether the toxin to the plasma membrane of host cells (17, 20, 21). This receptor
is present on the intestinal epithelium as well as motoneurons and sympathetic preganglionic
neurons (22). GM1 sorts the CT into lipid rafts and a retrograde trafficking pathway to the
endoplasmic reticulum, where the enzymatic subunit is transferred to the cytosol, probably
by dislocation through the translocon sec61P (20).
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To test the concept of receptor-mediated oral delivery of foreign proteins, we have
constructed a unique cholera toxin B–green fluorescent protein (CTB–GFP) fusion gene
with a furin cleavage site between CTB and GFP and expressed the fusion protein in
transgenic chloroplasts. Furin, a member of prohormone-proprotein convertases (23) (PCs),
is a ubiquitously expressed protein found in the trans-Golgi network (TGN) (24, 25),
endosomes, plasma membrane, and extracellular space (26). Furin cleaves protein precursors
with narrow specificity following basic Arg-Xaa-Lys/Arg-Arg-like motifs (27). The furin
cleavage site between CTB and GFP would, therefore, facilitate intracellular cleavage of the
target protein (GFP).
Transgenic leaves expressing the CTB-GFP or IFN-GFP fusion protein were fed to Balb/c
mice to investigate receptor-mediated oral delivery of foreign protein using CTB as a
transmucosal carrier across the intestinal epithelium. In this study, we show that CTB-GFP
binds to the intestinal mucous membrane, including the lymphoid tissue. Experimental
observations suggest that GFP is cleaved from CTB in the intestine through the action of
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furin and enters the mucosal vasculature. We show that GFP, but not CTB, is delivered to
the liver and spleen of the CTB-GFP fed mice. No significant levels of GFP were observed
in the liver and spleen of mice fed with IFN-GFP, which suggests that a transmucosal carrier
is essential for efficient delivery of proteins across the intestinal lumen. Thus, CTB
successfully delivers its fusion protein to the systemic circulation and supports the use of
transmucosal carriers in the delivery of therapeutic proteins.

MATERIALS AND METHODS
Construction of chloroplast vector

NIH-PA Author Manuscript

The pLD-CTB-GFP construct was based on the universal chloroplast vector pLD (Fig. 1)
that has been used successfully in our laboratory (28 –31). CTB-GFP construct was
engineered with a furin cleavage site, Pro-Arg-Ala-Arg-Arg, in between CTB and GFP. The
constitutive 16 s rRNA promoter was used to drive transcription of the aadA and the CTBGFP genes. The aminoglycoside 3′ adenylyltransferase (aadA) gene conferring
spectinomycin resistance was used as a selectable marker. The 5′-UTR from psbA,
including its promoter, was engineered to enhance translation of the CTB-GFP because it
has several ribosomal binding sites. The 3′ UTR region conferred transcript stability. A
GFP-IFN alpha5 fusion construct with a furin cleavage site between the two genes was
created and expressed in Nicotiana tabacam chloroplasts, which served as a control molecule
for the delivery of GFP without a transmucosal carrier.
Bombardment and selection of transgenic plants
The Bio-Rad PDS-1000/He biolistic device was used to bombard pLD-CTB-GFP onto
sterile Nicotiana tabacum cv. Petit Havana tobacco leaves, on the abaxial side as has been
described previously (29, 30, 32). The bombarded leaves were incubated in the dark for 24 h
and then placed on shooting media (RMOP) containing 500 μg/ml spectinomycin for two
rounds of selection.
PCR analysis to test stable integration
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DNA was isolated from the transgenic shoots by using Qiagen DNeasy Plant Mini Kit, and
PCR analysis was performed to confirm integration of the transgene in the inverted repeat
regions of the chloroplast genome. PCR reactions were performed with two sets of primers,
3P/3M and 5P/2M (28). The samples were denaturated for 5 min at 95°C followed by 30
cycles of the following temperatures: 95°C for 1 min, 65°C for 1 min, and 72°C for 2 min
and a 72°C hold for 10 min after all 30 cycles were completed. After confirmation of
transgenic plants, the shoots were then transferred to a rooting medium (MSO) with 500 μg/
ml spectinomycin as a selective agent.
Southern blot analysis
Total plant DNA was digested with EcoR1, separated on a 0.7% agarose gel at 45V for 8 h,
and then transferred to a nitrocellulose membrane. pUC-computed tomography vector DNA
was digested with BamHI and BglII to generate a 0.8 kb probe, which was used as a
flanking probe (28). After labeling the probe with with P32, hybridization of the membranes
was performed by using Stratagene QUICK-HYB hybridization solution and protocol
(Stratagene, La Jolla, CA).
Western blot analysis
Approximately 100 mg of leaf tissue was ground in liquid nitrogen and resuspended in 500
μl of plant extraction buffer (0.1% SDS; 100 mM NaCl; 200 mM Tris–HCl, pH 8.0; 0.05%
Tween 20; 400 mM sucrose; 2 mM PMSF). After centrifugation at 13,000 rpm for 5 min,
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the supernatant containing the extracted protein was collected. We boiled 10 μl of the plant
extract along with 10 μl of sample loading buffer, which was then run on a 15% SDS-PAGE
gel for 40 min at 50 V and then 2 h at 80 V. The protein was then transferred to
nitrocellulose membrane for 1 h at 80 V. After blocking the membranes with PTM (1× PBS,
0.05% Tween 20, and 3% dry milk) for 1 h, we added polyclonal rabbit anti-CTB primary
antibody (Ab) (Sigma) 1:3000 dilution. Goat anti-rabbit IgG conjugated to alkaline
phosphatase (Sigma) at a 1:5000 dilution was used as a secondary Ab.
Furin cleavage assay
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Approximately 100 mg of leaf material was powdered in liquid nitrogen and resuspended in
500 μl of plant extraction buffer containing 15 mM Na2CO3, 35 mM NaHCO3, 3 mM
NaN3, 5 mM CaCl2, and 0.5% Triton-X, 2-mercaptoethanol at pH 6.0 and 7.0. We added 1
mM PMSF to some of the samples. After centrifugation at 13,000 rpm for 5 min, the
supernatant containing the extracted protein was collected. The extract (20 μl) was
incubated at 30°C for 4 h with 4 U of furin. A control group was also incubated at 30°C for
4 h without furin. After 4 h, each sample was mixed with 20 μl sample loading buffer,
boiled, and run on 12% SDS-PAGE gel for 45 min at 80 V and then 2 h at 100 V. The
Western blot analysis was performed as per the procedure outlined above. Chicken anti-GFP
Ab (Chemicon) at a 1:3000 dilution was used as the primary Ab, and alkaline phosphatase
conjugated rabbit antichicken IgG (Chemicon) at a dilution of 1:5000 was used as a
secondary Ab.
ELISA
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The CTB-GFP quantification was done using the ELISA (ELISA). The standards and test
samples were diluted in coating buffer (15 mM Na2CO3, 35 mM NaHCO3, 3 mM NaN3,
pH 9.6). The standards, ranging from 50 to 500 ng, were made by diluting recombinant GFP
in 1% PBS. The leaf samples were collected from plants exposed to regular lighting pattern
(16 h light and 8 h dark), and total protein was extracted using plant protein extraction
buffer. Standard GFP dilutions (100 μl) and protein samples were bound to a 96-well plate
overnight at 4°C. The background was blocked with fat-free milk in PBST for 1 h at 37°C
followed by washing with PBST and water. Primary Ab used was polyclonal chicken antiGFP Ab (Chemicon) diluted (1:3000) in PBST containing milk powder. Secondary Ab was
HRP-conjugated rabbit anti-chicken IgG- secondary Ab (Chemicon) at a 1: 5000 dilution in
PBST containing milk powder. For the color reaction, 100 μl of 3,3_,5,5_-tetramethyl
benzidine (TMB from American Qualex) substrate was loaded in the wells and incubated for
10 –15 min at room temperature. The reaction was stopped by addition of 50 μl of 2N
sulfuric acid per well, and the plate was read on a plate reader (Dynex Technologies) at 450
nM.
GM1 binding assay
To test the functionality of CTB-GFP expressed in chloroplasts, a CTB-GM1 binding assay
was performed. We coated 96-well plates with 100 μl of monosialoganglioside- GM1
(Sigma) (3.0 ng/ml in bicarbonate buffer) and incubated them overnight at 4°C. After
washing with PBST and water, the standards and samples were incubated for 1 h at 37°C.
The plate was blocked with 1% BSA in 1× PBS for 1 h at 37°C. Rabbit anti-CTB primary
Ab (Sigma) and alkaline phosphatase (activating protein) conjugated goat anti-rabbit
secondary Ab (Sigma) was used to detect the CTB binding to GM1 receptor. The plates were
washed with PBST and water, and 200 μl of the substrate p-Nitrophenyl phosphate (PNPP)
was added to the wells and incubated in the dark at 37°C for 20 min. The reaction was
stopped by adding 50 μl of 3N NaOH, and the plates were read on a plate reader (Dynex
Technologies) at 405 nM.
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Three groups of 5-week-old female Balb/c mice were fed with CTB-GFP, IFN alpha5-GFP
(IFN-GFP), and wild-type (untransformed) plant leaf material. Leaves (350 mg) were
powdered in liquid nitrogen, mixed with peanut butter, and fed to the mice, which had been
starved overnight prior to this experiment. The mice were then gavaged for two more days,
two times a day, with 40 mg of leaf material per gavage that was powdered with liquid
nitrogen and mixed with 0.1M PBS (PBS). Five hours after the last gavage, the mice were
sacrificed and perfused with 10 ml of PBS followed by 4% paraformaldehyde in PBS. Fresh
frozen sections of the liver, spleen, ileum, and jejunum were collected according to Samsam
et. al (33). Additional tissue was removed and immersed in Tissue Tec freezing medium
(Vector labs) and immediately frozen in nitrogen-cooled isomethylbuthane (Sigma). Fixed
tissue was cryoprotected by passing through 10, 20, and 30% sucrose solutions in PBS.
Frozen sections (10 μm thick) of various tissues were then made using a cryostat.
Fluorescence microscopy and immunohistochemistry for GFP, CTB, and immune cells
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Frozen sections (10 μm thick) of intestine, liver, and spleen were mounted with PBS and
observed for GFP fluorescence using a Leica 4500 microscope. Immunohistochemistry was
performed in order to show the presence of GFP and/or CTB in various tissues. The slides
were first blocked with 10% BSA (BSA) and 0.3% Triton-X 100. Polyclonal chicken antiGFP (Chemicon) or polyclonal rabbit anti-CTB (Sigma) primary antibodies, at a
concentration of 1:500 and 1:300, respectively, in 1% BSA and 0.3% Triton-X, were used
for GFP or CTB localization of the tissues. Those sections processed for HRP conjugated
secondary antibodies were blocked with a mixture of methanol/hydrogen peroxide 30% (2:1
ratio) to block the endogenous peroxidases. The secondary antibodies were horseradish
peroxidase (HRP)-conjugated rabbit anti-chicken IgG (Chemicon) or HRP-conjugated goat
anti-rabbit (Sigma). Tissue-bound peroxidase was developed by using the 3,3′diaminobenzidine (3,3′-diaminobenzidine) as a substrate to visualize the immunoreaction.
For macrophage localization of the tissues, rat monoclonal F4/80 Ab (Serotec) was used
according to Berghoff et al. (34). The secondary Ab was Alexa-555 conjugated Goat anti-rat
IgG (Molecular Probes). American hamster anti-CD11c primary Ab and anti-hamster
Alexa-546 conjugated secondary Ab (Molecular Probes) were used to visualize dendritic
cells in the intestine and other tissues. FITC-labeled anti-chicken IgG was used as a
secondary Ab in such immunofluorescence staining to detect GFP in tissues.

RESULTS
Confirmation of transgene integration into chloroplast genome
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Nicotiana tabacum cv. Petit Havana leaves were bombarded with the pLD-CTB-GFP vector,
and the leaves were grown on selective medium containing 500 mg/l spectinomycin. The
resultant shoots were then screened for chloroplast transformants by PCR analysis by using
primers 3P/3M, and 5P/2M (Fig. 1A–C). The 3P primer lands on the native chloroplast
genome upstream of the site of integration, whereas the 3M primer lands on the aadA
transgene producing a 1.65 kb PCR product. This analysis ruled out the nuclear
transformants because 3P primer would not anneal and the spontaneous mutants are
eliminated because 3M primer would not anneal.
To check for the presence of the transgene in the chloroplast, we performed the 5P-2M PCR
analysis. The 5P primer lands on aadA gene and the 2M lands on the trnA coding sequence,
which produces a 2.9 kb PCR product with CTB-GFP. This confirmed the site-specific
integration of the CTB-GFP fusion gene in the inverted repeat regions of the chloroplast
genome.
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To further confirm the integration of the transgene into the chloroplast genome and to
determine whether homoplasmy had been achieved, Southern blot analysis was performed.
Total plant DNA was digested with the enzyme EcoR1 and hybridized with a chloroplast
flanking sequence probe (0.8 kb). Wild-type plants generated a 4.4 kb fragment, and
transgenic plants generated 4.9 and a 2.2 kb fragments (Fig. 1D). All of the transgenic lines
tested appeared to be homoplasmic (within the levels of detection), which means that all of
the chloroplast genomes within plant cells contained the transgene CTB-GFP.
GFP expression and assembly of CTB-GFP pentamers in transgenic lines
Figure 2 shows the transgenic and wild-type (WT) plants. In Fig. 2B, the GFP expression of
the transgenic plants can be seen under the UV light, which is not seen in the wild-type
(untransformed) plant (Fig. 2A). Fig. 2C shows WT plant, and Fig. 2D, the CTB-GFP
expressing plant under a low-magnification microscope. Expression of GFP is clearly
evident in Fig. 2D.
Western blot analysis was performed to investigate the expression of the fusion protein
CTB-GFP in transgenic tobacco chloroplasts (Fig. 3A). The pentameric form (188 kDa) was
observed in the unboiled samples of the transgenic plants, while predominantly the
monomeric form (37.6 kDa) was detected in boiled samples.
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Furin cleavage assay
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The protease furin is present in the constitutive secretory pathway and on the cell surface of
virtually all cells (35). An in vitro furin cleavage assay was performed on the CTB-GFP
expressing plant extract to show that the engineered cleavage site (Arg-Ala-Arg-Arg) was
recognized by furin. As seen in Fig. 3B, a 26 kDa polypeptide that corresponded with the
recombinant GFP protein was observed in the samples that were incubated with furin, thus
proving that furin could cleave CTB-GFP to release GFP. Furin cleavage occurred at both
pH 6.0 and 7.0 in the samples with and without PMSF. Still, some protein did not get
cleaved, probably because the amount of enzyme was not sufficient to cleave all the CTBGFP protein present in the plant extract. The incubation time of 4 h might also have been
insufficient. However, the presence of the cleaved GFP product in the samples incubated
with furin confirms that the engineered furin cleavage site is functional. The introduction of
furin consensus sequences at the B-chain/C-peptide and the C-peptide/A-chain interfaces of
human proinsulin has been demonstrated to increase the processing of proinsulin to mature
insulin in a wide variety of non-neuroendocrine cells, including fibroblasts, myoblasts,
epithelial cells, and lymphocytes (36 – 42). As the furin cleavage site is also recognized by
the endopeptidases PC2 and PC3/1, it is likely that CTB-GFP fusion protein is cleaved more
efficiently during the process of receptor-mediated delivery.
Quantification of CTB-GFP
To quantify the amount of CTB-GFP fusion protein in transgenic tobacco leaves, ELISA
(ELISA) was performed (Fig. 3B). A standard curve was obtained using different
concentrations of recombinant GFP. The amount of CTB-GFP in the transgenic plants was
compared with the known concentrations of the recombinant GFP (standard curve).
Expression levels of CTB-GFP ranged from 19.09 to 21.3% total soluble protein.
GM1 binding assay
The functionality of chloroplast-derived CTB-GFP was determined by its ability to bind to
GM1 in an in vitro GM1 binding assay (Fig. 3C). GM1 binding assay showed that pentamers
of CTB-GFP were formed. This finding confirms the correct folding and disulfide bond
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formation of CTB pentamers within transgenic chloroplasts because only the pentameric
form of CTB can bind to GM1 (21).
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Fluorescent microscopy to detect the presence of GFP in the tissue
Fixed tissue and fresh frozen sections of the liver, spleen, ileum, and jejunum were made
from the three groups of mice fed with plants expressing CTB-GFP, IFN-GFP, and WT
plants, respectively. In mice fed with CTB-GFP expressing plant leaf material, fluorescence
microscopy showed the presence of GFP in intestinal mucosa and submucosa (Fig. 4A), the
hepatocytes of the liver (Fig. 4D) as well as various cells of the spleen (Fig. 4G). In the mice
fed with wild-type (untransformed) leaf material, no GFP fluorescence was observed (Fig.
4B, E, and H). In the mice fed with IFN-GFP expressing plant leaf material, no GFP was
detected in the liver or spleen (Fig. 4F and I). Detection of GFP in the liver and spleen
following oral delivery of CTB-GFP expressing plant leaf material, suggests the successful
delivery of the protein across the intestinal lumen into the systemic circulation. Moreover,
the lack of detection of a significant amount of GFP in the liver and spleen of mice fed with
IFN-GFP expressing plants suggests that a transmucosal carrier such as CTB is required for
delivery of an adequate amount of a macromolecule across the intestinal lumen into the
systemic circulation.
Immunohistochemistry
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To confirm the fluorescent microscopy findings, immunostaining was performed with both
CTB and GFP antibodies. In the intestine of the mice fed with CTB-GFP, anti-GFP Ab
detected GFP inside the epithelial cells of the villi of the intestine, in the crypts, as well as in
the submucosal tissue (Fig. 5 A, C), which suggesting GFP uptake by lymphoid cells as well
as the circulation. These results confirmed the previous microscopy find-ings (Fig. 4) and
showed the presence of GFP in various tissues, confirming that GFP was successfully
delivered to blood when transgenic leaf material was orally fed to the mouse. GFP
immunoreactivity was detected in the liver and spleen (Fig. 5E and H) in a similar pattern to
that seen with fluorescence microscopy of the native tissue (Fig. 4D and G). In the case of
the mice fed with wild-type leaf material, no GFP was detected in any of the tissues (Fig. 5F
and I). In the mice fed with plants expressing IFN-GFP, GFP was not detected in the liver or
spleen cells (Fig. 5G and J).
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To study the route of CTB in the body, we performed immunohistochemistry using antiCTB antibodies. CTB was detected in the intestinal cells as well as inside the villi (Fig. 6A)
in the lamina propia and the submucosa. It was, however, not detected in the liver (Fig. 6E),
indicating that GFP is cleaved away from CTB and that, while GFP leaves the cell, CTB
probably is translocated to the basolateral membrane of the cell. These results support the
feasibility of CTB to act as a transmucosal carrier and orally deliver fused proteins via the
intestinal cells.
To localize the GFP and/or CTB in the gut associated lymphoid tissue (GALT) and other
tissues, double staining for antigen-presenting cells such as macrophages or dendritic cells
was performed. A double staining with F4/80 Ab for macrophages showed the presence of
CTB inside macrophages (Fig. 6C). Fig. 6G shows macrophages associated with GFP, and
Fig. 6I shows dendritic cells taking up the GFP. In either case, associations of GFP with
these antigen presenting cells were found. Most of the macrophages were not associated
with GFP, which is perhaps due to uptake by the blood and lymph circulation, while the
CTB is translocated to the basolateral membrane and is associated with macrophages.
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In this study, detection of GFP and CTB in the intestinal mucosa (Figs. 5, 6) suggests that
CTB–GFP has been taken up by the enterocytes and the gut-associated lymphoid tissue
(GALT). The CTB domain of the CTB-GFP forms the pentameric structure within
chloroplasts through disulfide bond formation; pentameric form binds to the GM1 receptors
on enterocytes and is endocytosed into the intestinal cells as endosomes (20). GM1 functions
to concentrate CTB in detergent-insoluble, glycolipid-rich apical membrane microdomains
called lipid rafts (43, 44). Binding to lipid rafts is required to couple the lipid-anchored
protein with intracellular machinery for protein sorting and vesicular traffic (45, 46). After
endocytosis, the CTB-GM1 complex trafficking occurs retrogradely through Golgi cisternae
and/or TGN (20, 47) into the lumen of the endoplasmic reticulum (ER; 48). The GM1-CTBGFP complex in the lipid rafts, targeted to the TGN, loses its endosomal covering. Within
the TGN, ubiquitously expressed furin cleaves numerous polypeptide precursors as it gets
activated. In eukaryotes, many essential secreted proteins and peptide hormones, enzymes,
and neuropeptides are initially synthesized as proproteins (inactive precursors) and are
activated by proteolytic cleavage by furin and other members of the prohormone-proprotein
convertase (PCs, 23). Abundant experimental evidence indicates that the CTB-GFP protein
with furin cleavage site in between the fusion protein gets cleaved and, as a result, the CTB
and GFP separate. The CTB is taken into the ER and from there to the basolateral surface of
the cell (transcytosis), where it remains membrane bound to GM1 receptor (20). The GFP
molecule getting out of the TGN (presumably membrane-bound) is exocytosed through the
basolateral membrane and finds its way into extracellular fluid and into the submucosal
vessels, including the lymphatic system. Due to the large-size fenestrations of the lymphatic
vessels, lymphatics return over 3 L of fluid and ~120 g of protein to the bloodstream every
24 h in an adult human (49).
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Besides the entry of CTB-GFP through the GM1 ganglioside receptor, the M cells in
intestinal epithelium covering the mucosa-associated lymphoid tissue in the digestive tract
also serve as a port of entry of macromolecules and microorganisms by pinocytosis (50).
Therefore, a small amount of CTB-GFP could be taken up by the GALT. This is shown in
our study by CTB and GFP expression in the antigen presenting cells, including the
macrophages as well as the dendritic cells in the intestinal lamina propia and submucosa.
Similarly, a small amount of GFP associated with macrophages in the intestine of the INFGFP fed mice is likely to be taken up by the M cells nonspecifically. The IFN-GFP fusion
protein also contains a furin cleavage site but, due to limited uptake by the intestinal
epithelial cells, there is not a significant GFP transport to the tissues of the IFN-GFP fed
mice. The amount of CTB-GFP reaching the enterocytes via GM1 receptor is very high
compared with the entry of IFN-GFP through M cells. This is quite evident due to the GFP
detected in various organs of the CTB-GFP fed mice (Figs. 5, 6). Presence of GFP and not
CTB in the liver of CTB-GFP treated mice in our study (Figs. 5, 6) suggests the cleavage of
the CTB-GFP fusion protein in entero-cytes and uptake of GFP into the vasculature of the
lamina propia and the submucosa. CTB, however, might be translocated to the basolateral
cell membrane and remain bound to GM1 (20).
The main goal of this study is to develop an efficient oral delivery of protein through GM1
receptor-mediated endocytosis. Moreover, furin cleavage site facilitates the cleavage of the
candidate protein in the cell, so that it could be passed into the extracellular space and into
the circulation. Internalization of GFP using receptor- mediated endocytosis suggests a
possible way of protein delivery across the impermeable intestinal mucous membrane.
Because of the rapid turnover of the intestinal epithelial cells (51) in humans (renewal of the
intestinal epithelium occurs in every 3– 6 d), repeated feeding of the CTB fused to a
therapeutic protein is possible due to the continuous availability of GM1 receptors in the
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new epithelium. Moreover, Peterson and colleagues suggested a recycling mechanism for
GM1 receptor as well (52).
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One of the most challenging problems of human health management is the high cost of
prescription drugs in developed countries and their lack of availability in developing
countries. Such high cost of therapeutic proteins can be attributed to their production in
fermentation-based system, expensive purification and processing methods, low-temperature
storage, transportation, and sterile delivery using syringes through health professionals.
Most of these expenses could be avoided by expressing therapeutic proteins in plant cells
and through their oral delivery. This study shows internalization of CTB-GFP by the mouse
intestinal mucosal cells as well as the antigen-presenting cells in the intestinal mucosa and
submucosa. We also show the presence of GFP but not CTB in the liver of mice following
oral delivery of CTB-GFP leaf material. Detection of both CTB and GFP in mouse intestinal
cells following oral administration of CTB-GFP expressing leaf material shows that the
recombinant protein has been protected from peptidases and/or acids by bioen-capsulation
(53) within the plant cells. Several vaccine antigens (28, 54 –57) and human blood proteins
(31, 58 – 60) have been expressed in transgenic chloroplasts and shown to be fully
functional. The ability to express high levels of foreign proteins in plastids present within
edible plant parts (61, 62) and the rapid turnover of intestinal epithelial cells (51) for
recycling GM1 receptors make this approach a reality. This study opens the door for lowcost production and delivery of human therapeutic proteins.
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Figure 1.

PCR analysis for the confirmation of transgene integration. A) Schematic representation of
the transgene cassette. B) 5P/2M—These primers land on the aadA and trnA regions
(flanking the CTB-GFP). A 2.9 kb PCR product was obtained from the PCR analysis of
trasgenic plants. C) 3P/3M—The 3P primer lands on the native chloroplast genome and the
3M primer lands on the aadA gene. A 1.6 kb PCR product was obtained from the PCR
anlysis of the transgenic plants. Lane 1: 1 kb plus ladder. Lanes 2–5: Transgenic lines of
CTB-GFP. Lane 6: Positive Control. Lane 7: Empty. Lane 8: Wild-type Plant. D) Southern
blot analysis of the plants. Lane 1: WT showing 4.4 kb fragment. Lanes 2–5: Transgenic
plants showing 4.9 and 2.2 kb hybridizing fragments. Flanking sequence shown in Figure
1A was used as the probe.
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Figure 2.

Visualization of GFP fluorescence in transgenic plants under UV light. A) Wild-type
(untransformed) plant seen under UV light. B) CTB- GFP expressing leaf showing
fluorescence observed under UV light. C) Wild-type leaf under a low-magnification
microscope. D) CTB-GFP expressing leaf showing fluorescence under a low-magnification
microscope.

NIH-PA Author Manuscript
NIH-PA Author Manuscript
FASEB J. Author manuscript; available in PMC 2012 October 26.

Limaye et al.

Page 15

NIH-PA Author Manuscript
NIH-PA Author Manuscript
Figure 3.
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Immunoblot analysis, furin cleavage assay and quantification of CTB-GFP expressed in
chloroplasts of transgenic lines. A) Immunoblot demonstrating the expression of CTB-GFP
in transgenic plant crude extracts: Lane 1: Un-boiled crude extract of transgenic line A. Lane
3: boiled crude extract of transgenic line A. Lane 5: Unboiled crude extract of transgenic
line B. Lane 6: Boiled crude extract of transgenic line A. Lane 8: Purified CTB standard 200
ng. Lane 9: Wild-type plant crude extract. Lanes 2, 4, 7: empty. B) Furin cleavage assay of
the plant extract: Lane 1: Marker. Lane 2: CTB-GFP, pH 6.0, with furin, no PMSF. Lane 3:
CTB-GFP no incubation, no furin. Lane 4: CTB-GFP pH 6.0 with furin and PMSF. Lane 5:
CTB-GFP, pH 7.0, with furin and PMSF. Lane 6: CTB-GFP, pH 6.0, with PMSF, no furin.
Lane 7: CTB-GFP, pH 6.0, no PMSF, no furin. Lane 8: Blank. Lane 9: Purified recombinant
GFP standard. C) Expression levels in % of CTB-GFP in total soluble protein (TSP) of the
CTB-GFP expressing plants. D) GM1 ganglioside binding assayshowing the presence of
CTB-GFP functional pentamers.
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Figure 4.
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Cryosections of the intestine and liver of the mice fed with CTB-GFP or wild-type plant
leaves material. A) GFP in the ileum of a mouse following oral delivery of the CTB-GFP
expressing plant leaf material. Arrows show numerous columnar cells of the intestinal
mucous membrane, which have up-taken the CTB-GFP. Various cells in the connective
tissue beneath the epithelium also show the presence of GFP. B) Section of the ileum of a
mouse fed by the wild-type (untransformed) plant leaf material. C) Section of the ileum of a
mouse fed by the IFN-GFP leaf material. D) GFP in hepatocytes of a mouse liver following
oral delivery of CTB-GFP expressing plant. E) Section of the liver of a mouse fed by the
wild-type plant material. F) Section of the liver of a mouse fed by IFN- GFP expressing
plant material. G) GFP in the spleen of a mouse following oral delivery of CTB-GFP
expressing plant. Arrows show various splenic cells with GFP. H) Section of the spleen of a
mouse fed by the wild-type plant material. I) Section of the spleen of a mouse fed by IFNGFP expressing plant material. Scale bar: 50 μm.
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Figure 5.
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Immunohistochemical localization of the GFP in mouse ileum, liver, and spleen. A–C) are
sections of the ileum of the mice fed with CTB-GFP expressing plant leaf. Arrows indicate
presence of GFP in the intestinal epithelium as well as cells of the crypts. D) Shows a
section of the ileum of a mouse fed with wild-type (untransformed) plant leaf materials. E)
GFP- immunoreactivity in hepatocytes (arrows) in a mouse fed orally by CTB-GFP
expressing plant. F) Section of the liver from a mouse fed by wild-type (untransformed)
plant. G) Section of the liver from a mouse fed by IFN-GFP expressing plant. H) GFPimmunoreactivity in the spleen of mouse fed orally by CTB-GFP expressing plant. Arrows
indicate various cells with a higher GFP content. I) Section of the spleen from a mouse fed
by wild-type (untransformed) plant. J) Section of the spleen from a mouse fed by wild-type
(untransformed) plant. Scale bar for A–D = 50 μm, Scale bar for E–J = 25 μm.
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Figure 6.
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Immunohistochemistry of ileum, liver, and spleen tissues of mice fed with CTB-GFP
expressing leaves or IFN-GFP expressing leaves or wild-type leaves. A) Shows a section of
the intestine of a CTB-GFP treated mouse. The arrows indicate CTB in the submucosa of
the intestinal villi. B) Shows a section of mouse ileum fed with wild-type plant,
immunostained for CTB. C–F) Double staining for macrophage (red) and CTB (green) in
mouse intestine and liver. C) Arrows show macrophages in the sub-mucosa of the intestine
containing CTB, in a mouse fed with CTB-GFP expressing plant leaf material. The merged
color is yellow. D) Arrows indicate F4/80-positive cells (macrophages, in red) in a merged
picture in the intestine of a mouse fed with WT leaf material. E) A merged picture showing
double staining for macrophage (Kupffer cells) and CTB in mouse liver. Arrows show
macrophages (red) in the liver. No sign of CTB (green) was found in the liver of CTB-GFP
fed mouse. F) Liver section of an IFN-GFP fed mouse used as a negative control for CTB.
Macrophages are seen in red. G) F4/80 Ab was used as a marker of macrophages in the
intestine. Arrows indicate macrophages, which have entrapped GFP (yellow after merging
the red and the green). Many of the macrophages are not associated with GFP. H) Many
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macrophages are seen in the intestine of mouse fed with IFN-GFP expressing plant leaf
material, which do not show GFP immunoreactivity. I, J) CD11c (red) and GFP (green)
immunoreactivities in the mouse intestine. I) Arrows indicate CD11c (red, presumably
dendritic cells, due to having a star shape morphology) with internalized GFP (green), which
can be seen in yellow color when the red and green channels were merged. J) Arrows
indicate CD11c-positive cells in intestine of mice fed with IFN-GFP expressing plant leaf
material. Scale bar for A and B = 25 μm. Scale bar for C–J = 50 μm.
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